ARS Pharmaceuticals had a revenue of 32.50M in the quarter ending Sep 30, 2025, with 106.79%. This bring the company's revenue in the last twelve months to 142.77M, Decreased 27.09%. In the fiscal year ending Dec 31, 2024, ARS Pharmaceuticals had annual revenue of 89.15M with 297063.33% growth.